The current management of COVID-19 is mostly limited to general supportive care and
symptomatic treatment. Ivermectin is a broad-spectrum anti-parasitic drug used widely for …

Angiotensin converting enzyme 2 (ACE2) is a main receptor for SARS-CoV-2 entry to the
host cell. ACE2 is one of the key enzymes in renin-angiotensin system and plays a vital role …

Background: In 2019, a new type of coronavirus emerged and spread to the rest of the world.
Numerous drugs were identified as possible treatments. Among the candidates for possible …

Growing evidence indicates that hyperinflammatory syndrome and cytokine storm observed
in COVID-19 severe cases are narrowly associated with the disease's poor prognosis …

Update on human genetic susceptibility to COVID-19: susceptibility to virus and response |
Human Genomics Skip to main content SpringerLink Account Menu Find a journal Publish with …

Purpose: To evaluate the safety and efficacy of remdesivir in adult patients with COVID-19.
Methods: PubMed, Embase, Scopus, Web of Science, Cochrane Library, ClinicalTrials. gov …

Abstract Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing public health emergency …

Purpose: Since December 2019, coronavirus disease 2019 infection has become a global
pandemic. The cases of Coronavirus Disease 2019 (COVID-19)-related acute cardiac injury …

Infection by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can trigger
excessive interleukin (IL)‐6 signalling, leading to a myriad of biological effects including a …

Inflammation is a culprit in many conditions affecting millions of people worldwide. A
plethora of studies has revealed that inflammation and inflammatory mediators such as …